Pratt Collard Advisory Partners’s Pfizer PFE Stock Holding History

Pratt Collard Advisory Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.19M	Buy	30,299 +192	+0.6%	+$7.47K	0.79%	42
2021 Q1	$1.09M	Sell	30,107 -5,351	-15%	-$190K	0.78%	41
2020 Q4	$1.3M	Sell	35,458 -2,139	-6%	-$78.5K	0.95%	30
2020 Q3	$1.31M	Buy	37,597 +91	+0.2%	+$3.19K	1.07%	26
2020 Q2	$1.16M	Sell	37,506 -13,904	-27%	-$472K	1.04%	33
2020 Q1	$1.59M	Sell	51,410 -8	-0%	-$273	1.6%	18
2019 Q4	$1.91M	Sell	51,418 -3,968	-7%	-$141K	1.46%	22
2019 Q3	$1.89M	Sell	55,386 -202	-0.4%	-$7.34K	1.49%	22
2019 Q2	$2.29M	Sell	55,588 -2,269	-4%	-$90.1K	1.8%	16
2019 Q1	$2.33M	Sell	57,857 -1,752	-3%	-$70.2K	1.86%	13
2018 Q4	$2.47M	Sell	59,609 -2,341	-4%	-$97.2K	2.24%	7
2018 Q3	$2.59M	Sell	61,950 -15,471	-20%	-$596K	2.07%	9
2018 Q2	$2.67M	Sell	77,421 -9,000	-10%	-$308K	2.3%	8
2018 Q1	$2.91M	Buy	86,421 +2,668	+3%	+$91.7K	2.54%	6
2017 Q4	$2.88M	Buy	+83,753	New	+$2.86M	2.37%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pratt Collard Advisory Partners's PFE Position: Q2 2021 in Review

Pratt Collard Advisory Partners increased its Pfizer (PFE) stake by 0.64% in Q2 2021, buying an estimated $7.47K and bringing the position to 30,299 shares worth $1.19M. The position accounts for 0.79% of the portfolio, ranked #42.

Pratt Collard Advisory Partners first reported a position in PFE in Q4 2017 and has held it in 15 quarters since. The position peaked at $2.91M in Q1 2018. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Pratt Collard Advisory Partners held 30,299 shares of Pfizer worth $1.19M as of Q2 2021.
Pratt Collard Advisory Partners bought 192 Pfizer shares in Q2 2021, an estimated $7.47K.
Pfizer made up 0.79% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #42 holding.
Pratt Collard Advisory Partners first reported a position in Pfizer in Q4 2017 and has held it in 15 quarters since.
Pratt Collard Advisory Partners's Pfizer position peaked at $2.91M in Q1 2018.
2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.